AVD AMERICAN VANGUARD CORP Insider Trading

CEO Douglas Kaye buys 5,000 AVD shares at $2.50; stock down 55.1% from 52-week high, company unprofitable

Douglas Kaye, Chief Executive Officer of American Vanguard Corp, purchased 5,000 shares at $2.50 on 2026-06-03, adding to his 295.3K share position. The purchase occurred as AVD trades at $2.66, down 55.1% from its 52-week high of $5.92 and down 12.2% over the trailing 30 days. Fundamentally, the company reported net income of $-4.1M against revenue of $123.6M, reflecting a loss position over its most recent full fiscal year. Kaye's prior buy at this ticker on 2025-06-11 showed positive 90-day performance (+15.4%), though his recent 30-day return was negative (-15.6%), indicating a historical pattern of eventual recovery despite short-term declines.

Director Patrick E Gottschalk bought 25,000 shares of AVD at $2.70; stock -54.9% from 52-week high, company unprofitable.

Director Patrick E Gottschalk purchased 25,000 shares at $2.70, bringing his holdings to 191,705 shares (+15.0% vs pre-transaction holdings), while AVD trades at $2.67 after declining -54.9% from its 52-week high of $5.92. The company reported negative net income of $-4,145,000.00 in the latest quarter and declining annual revenue growth of -5.9%, with full-year profitability also negative. The timing of this purchase amid substantial stock decline and operational underperformance warrants investor attention to underlying business trends.

Director Gottschalk purchases 40,000 shares in 2 transactions at $2.92–$2.95 as AVD trades -54.9% from 52-week high amid unprofitability.

Gottschalk Patrick E executed 2 separate purchases totaling 40,000 shares for $117,400.00 on 2026-05-12 and 2026-05-13 at a blended average price of $2.94, increasing his holdings by 31.6% from 126.7K to 166.7K shares. The purchases occur while American Vanguard trades at $2.67, down 54.9% from its 52-week high of $5.92, and the company reported a negative net income of $-4.1M on quarterly revenue of $123.6M with annual revenue declining 5.9% year-over-year. His prior trading at this ticker (August 2023 buy) is not yet measurably timed at 90 days, and cross-ticker history shows only 1 prior buy with no pattern of well-timed acquisitions. The magnitude of this accumulation and the depressed price context relative to 52-week range merit attention, but the company's unprofitability and negative growth trajectory must factor into any investor assessment of the underlying risk.

AVD CEO Kaye Douglas buys 2,000 shares at $4.67 amid -5.5% annual revenue decline and negative net income of $-8.5M

Kaye Douglas, Chief Executive Officer, purchased 2,000 shares at $4.67, increasing holdings to 290,461 shares. This occurs in a challenging operational context: American Vanguard reported quarterly revenue of $115.8M but net income of $-8.5M, with annual revenue declining 5.5% year-over-year and the company unprofitable over its most recent full fiscal year. The stock is trading at $4.52 (current price), down 53.0% from its 52-week high of $9.62, though it has gained 2.5% over the past 30 days. The purchase represents a modest 0.7% increase to the CEO's holdings and involves a small dollar amount of $9,340.00 relative to the company's $128.2M market capitalization.

Director Macicek buys 12,000 AVD shares at $5.97; holds recovered from -53.0% 52-week trough.

Steven D Macicek, a director at American Vanguard, purchased 12,000 shares (12.0K shares) at $5.97 on 2024-11-15, expanding his holdings by 62.4% to 31,218 shares (31.2K shares). The purchase occurred near the 52-week low range; at $5.97, the stock was -53.0% from its 52-week high of $13.10. However, Macicek's cross-ticker track record reveals a pattern of poorly-timed buys: his three prior open-market purchases across all tickers averaged 90-day returns of -37.6%, with a 0.00% win rate at the 90-day mark. At American Vanguard specifically, all three of his prior trades (each on 2024-05-15) also showed negative 90-day outcomes, ranging from -37.4% to -37.8%. The company's fundamentals show strain: net income of $-25.7M in the latest quarter against revenue of $118.3M, with annual revenue declining 5.0% year-over-year. This purchase merits observation given the history of poor timing and the company's negative earnings environment.

Director Keith M Rosenbloom purchases 136,492 shares (136.5K) for $790,844.08 across 3 transactions at blended $5.79 amid -55.4% decline from 52-week high.

Director Keith M Rosenbloom executed 3 separate purchases totaling 136,492 shares for $790,844.08 from August 30 through September 4, 2024, increasing his holdings by 12.8% to 1,200,682 shares. The timing coincides with significant negative momentum: the stock has declined 55.4% from its 52-week high of $13.76 and fallen 28.8% over the past 30 days, trading at $6.13 versus his blended purchase price of $5.79. His prior trading history at AVD shows a poor record: of 5 prior trades at this ticker with measurable outcomes, only 1 of 3 prior buys produced positive 90-day returns (23.4% gain on 2023-11-21), while two other buys declined 36.6% and 12.2% respectively over 90 days. Against this backdrop of weak fundamentals (net income of $-11.7M in the latest quarter, 5.0% annual revenue decline, P/E of 22.70), the large concentrated purchase at depressed prices warrants scrutiny of the underlying operational issues.

Director Keith M Rosenbloom buys 16,480 shares of AVD at $5.74; stock down 57.3% from 52-week high

Keith M Rosenbloom, as Director, purchased 16,480 shares on 2024-08-29 at $5.74, bringing his total holdings to 1,064,190 shares. The purchase occurred against a severely depressed backdrop: the stock has fallen 57.3% from its 52-week high of $13.82 and dropped 33.3% over the prior 30 days alone. At the ticker-specific level, Rosenbloom has made three purchases in the past five days (2024-08-28, 2024-08-30, and 2024-09-03), suggesting rapid accumulation during weakness. However, his same-ticker history is mixed: a prior buy on 2024-05-15 resulted in a 90-day decline of -36.6%, while his cross-ticker track record shows a 90d win rate of only 14.29% despite a modest 30-day average return of +2.8%. Meanwhile, the company is unprofitable (net income of -$11.7M on revenue of $128.2M) and experienced 5.0% revenue contraction year-over-year. The rapid accumulation pattern in a distressed environment warrants closer examination of what may be driving this aggressive insider buying.

AVD director ROSENBLOOM bought 33,555 shares at $5.66 on 2024-08-28, stock down 60.5% from 52-week high of $14.53.

Keith M. Rosenbloom, a director of American Vanguard Corp, purchased 33,555 shares at $5.66 on 2024-08-28, expanding his holdings to 1,047,410 shares. The stock has declined sharply, trading at $5.74 currently—down 60.5% from its 52-week high of $14.53 and down 40.3% over the past 30 days. At the same ticker, Rosenbloom's prior buy on 2024-05-15 saw a 90-day return of -36.6%, while his buy on 2023-11-21 achieved a +23.4% 90-day return; across his broader cross-ticker history, his 9 prior buys averaged -10.2% over 90 days with only a 14.29% win rate. The company posted a net loss of $-11.7M in its latest quarter against revenue of $128.2M, with annual revenue declining 5.0% year-over-year. This purchase occurs amid both significant stock depreciation and operational headwinds, with mixed signals from Rosenbloom's own timing history at this ticker.